Found 0 matching trials
Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea PHASE1 Current therapies available for obstructive sleep apnea (OSA) have varying ...
Show More Location
Brigham and Womens Hospital
Learn More & Join Trial
Crossover Trial of AD036 in Obstructive Sleep Apnea PHASE2 This is a randomized, 3-Period, Placebo-Controlled, Crossover, phase 2 clin...
Show More Location
Preferred Research Partners, Inc.
Learn More & Join Trial
Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia PHASE3 This is a randomized, placebo-controlled study to assess the efficacy and s...
Show More Location
LaRue Carter Hospital
Learn More & Join Trial
Treatment Drop-out and Missed Appointments Among Adults With ADHD N/A The investigators knowledge of factors associated with treatment drop-out a...
Show More Location
Psychiatric Research Unit West, Regional Psychiatric Services West
Learn More & Join Trial
Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder NA The purpose of this study is to find out whether atomoxetine (also called S...
Show More Location
Denver Health Medical Center
Learn More & Join Trial
Orthostatic Intolerance After Bariatric Surgery PHASE1 More than 78 million adults in the U.S. are obese. Bariatric surgery is the...
Show More Learn More & Join Trial
Pharmacological Agents for Chronic Spinal Cord Injury (SCI) PHASE1 The purpose of this study is to investigate the short-term effects of 3 app...
Show More Location
James J. Peters Veterans Affairs Medical Center
Learn More & Join Trial
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine EARLY_PHASE1 This study is aimed at determining if the drug Atomoxetine (Strattera-used ...
Show More Location
Univerisity of Maryland, Baltimore
Learn More & Join Trial
A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents PHASE4 The main purpose of the study is to help to understand the effect on childr...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) PHASE2 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults with Attention-De...
Show More Location
Site Reference ID/Investigator# 5965
Learn More & Join Trial